Manoj Gopi

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Energy Transfer

Top Venues

Drug development research

BMC research notes

Journal of immunoassay & immunochemistry

Sree Chitra Tirunal Institute for Medical Sciences and Technology

Osmania University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sree Chitra Tirunal Institute for Medical Sciences and Technology Aug 29 2018

India

Scientist D :: Artificial Internal Organs

HLL Lifecare Ltd Mar 01 2011 - Aug 28 2018

India

Scientist E2 :: Corporate R&D Centre

Aurora Oct 01 2010 - Feb 01 2011

India

Asst. Professor :: Dept. of Biotechnology

Centre for Stem Cell Science Jan 01 2005 - Oct 01 2010

India

Research Scholar :: Center for Liver Research & Diagnostics

Education History

Osmania University

India

PHD :: Dept. of Genetics

Publications

Vani M, Anugya Bhatt, Anoopkumar Thekkuveettil, Sanjay Ganapathy, Jeemon Panniyammakal, Harikrishnan Sivadasanpillai, Manoj Gopi
To evaluate the feasibility of cadmium/tellurium (Cd/Te) quantum dots for developing N-terminal Natriuretic Peptide (NT-proBNP) in-vitro diagnostics. Journal of immunoassay & immunochemistry (2022)
Vani Maya, Jyothi Embekkat Kaviyil, Dinoop Koral Ponnambath, Renjith P Nair, Anugya Bhatt, Rajendra Pilankatta, Lathika Valliyot, Ranjeet Dungdung, Ramdas Athikkal Veettil, Manoj Gopi
Evaluation of diagnostic accuracy of developed rapid SARS-COV-2 IgG antibody test kit using novel diluent system. Virusdisease (2021)
Saikant Regidi, Shilpa Ravindran, Ashitha L Vijayan, Vani Maya, Lakshmi Sreedharan, Jeslin Varghese, Kartik Ramaswami, Manoj Gopi
Effect of lyophilization on HRP-antibody conjugation: an enhanced antibody labeling technology. BMC research notes 11 (1) (2018)
Lakshmi Sreedharan Pillai, Saikant Regidi, Shiny Deena Varghese, Shilpa Ravindran, Vani Maya, Jesline Varghese, Kartik Ramaswami, Rajmohan Gopimohan, Manoj Gopi
Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer. Drug development research 79 (6) (2018)